One: Echo-enhancement agents: basic aspects. - 1. Contrast echocardiography a historical perspective. - 2. Microbubble fluid dynamics of echocontrast. - 3. Physics of microbubble scattering. - 4. Spontaneous echocontrast: etiology technology dependence and clinical implications. - 5. Echo-enhancing agents: their physics and pharmacology. - 6. Echo-enhancing agents: safety. - 7. Behavior of echocontrast microbubbles in the microvasculature. - 8. Imaging instrumentation for ultrasound contrast agents. - 9. Doppler myocardial imaging. - 10. Quantitative Doppler intensitometry. - Two: Contrast echocardiography: clinical aspects. - 11. Contrast echocardiography today. - 12. Clinical use of contrast agents: technical (practical) considerations. - 13. Right heart echo-enhancement in the assessment of pulmonary artery pressures and right ventricular function. - 14. Contrast-enhanced color Doppler in the assessment of mitral Regurgitation. - 15. Contrast-enhanced Doppler in the assessment of aortic stenosis. - 16. Detection of intrapulmonary vasodilatation and diagnosis of hepatopulmonary syndrome using contrast echocardiography. - 17. Identification of right-sided structures by contrast transesophageal echocardiography with emphasis on patent foramen ovale. - 18. Contrast echo-enhancement during transesophageal echocardiography: indications and clinical benefits. - 19. Transesophageal echocardiographic assessment of coronary flow reserve and coronary artery stenosis using echo enhancement. - 20. Left ventricular contrast echocardiography echoventriculography stress echocardiography. - 21. Contrast color flow Doppler evaluation of the left ventricle. - 22. Usefulness of echo enhancement in stress echocardiography (USA experience). - 23. Assessment of myocardial perfusion with variousintravenous echo-enhancing agents. - 24. Myocardial contrast echocardiography in ischemic heart disease: Osaka experience. - 25. Assessment of myocardial viability post-infarction with myocardial contrast echocardiography. - 26. Can myocardial echocontrast replace thallium?. - 27. Intraoperative applications of contrast echocardiography. - 28. Harmonic imaging during contrast echocardiography: basic principles and potential clinical value. - 29. Transient response imaging during contrast echocardiography. - 30. Three-dimensional echocardiographic assessment of myocardial perfusion abnormalities. - 31. Three-dimensional visualization of myocardial perfusion using contrast echocardiography. - Three: Echo-enhancement agents in Doppler vascular sonography. - 32. Usefulness of echo-enhancement in Doppler assessment of carotid arteries. - 33. Contrast-enhanced transcranial color Doppler imaging. - 34. The promise of sonographic contrast agents in the kidney. - 35. Ultrasound contrast agents in peripheral vascular disease. - 36. Clinical usefulness of color Doppler enhancement in the assessment of the liver and the portal system. - 37. Echo-enhancing agents in tumors. - 38. Examination of efficacy of SHU 508A for color Doppler sonography of peripheral vascular diseases and soft tissue tumors in the pelvis and extremity. - 39. Contrast-enhanced color Doppler in the diagnosis of liver tumors. - Four: Work in progress. - 40. Visualization of intramyocardial vasculature by contrast Echocardiography. - 41. Visualization of intramyocardial coronary vessels by color Doppler. - 42. Development of a novel site-targeted ultrasonic contrast agent. - 43. Acoustically stimulated microbubbles in diagnostic ultrasound: properties and implications for diagnostic use. - 44. Microvascular imaging results from aphase I study of the novel polymeric ultrasound contrast agent SHU 563A. Language: English